Lam Research (NASDAQ:LRCX – Get Free Report) updated its first quarter 2027 earnings guidance on Wednesday. The company provided EPS guidance of 2.000-2.300 for the period, compared to the consensus estimate of 1.810. The company issued revenue guidance of $7.7 billion-$8.5 billion, compared to the consensus revenue estimate of $7.0 billion.
Lam Research Stock Performance
Shares of LRCX traded up $43.32 during mid-day trading on Thursday, hitting $295.67. 13,462,649 shares of the company traded hands, compared to its average volume of 11,374,592. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.77 and a current ratio of 2.54. Lam Research has a 1 year low of $90.93 and a 1 year high of $438.50. The stock has a market cap of $369.76 billion, a price-to-earnings ratio of 55.80, a P/E/G ratio of 1.60 and a beta of 1.80. The stock has a 50-day moving average price of $341.14 and a two-hundred day moving average price of $275.79.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same quarter in the prior year, the company earned $1.33 earnings per share. Lam Research’s revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities analysts anticipate that Lam Research will post 5.68 earnings per share for the current year.
Lam Research Announces Dividend
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the stock. Sanford C. Bernstein lifted their price objective on shares of Lam Research from $325.00 to $340.00 and gave the company an “outperform” rating in a report on Thursday, May 21st. TD Cowen reiterated a “buy” rating and issued a $400.00 target price (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. Barclays reissued an “overweight” rating and set a $335.00 price target (up from $275.00) on shares of Lam Research in a research report on Thursday, June 11th. BNP Paribas Exane boosted their price objective on shares of Lam Research from $250.00 to $260.00 and gave the stock a “neutral” rating in a research note on Thursday, April 23rd. Finally, Wall Street Zen lowered Lam Research from a “buy” rating to a “hold” rating in a research report on Sunday, May 10th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $358.47.
Check Out Our Latest Stock Analysis on LRCX
Insider Buying and Selling
In other news, SVP Neil J. Fernandes sold 18,170 shares of the stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $255.14, for a total value of $4,635,893.80. Following the transaction, the senior vice president directly owned 66,129 shares of the company’s stock, valued at approximately $16,872,153.06. This represents a 21.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the firm’s stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 98,611 shares of company stock worth $32,250,190 in the last 90 days. Insiders own 0.31% of the company’s stock.
Key Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam Research reported record quarterly revenue of $6.72 billion, up 30% year over year, while adjusted EPS of $1.82 exceeded the $1.69 consensus estimate. Reuters article
- Positive Sentiment: Fiscal first-quarter 2027 guidance was well above expectations: revenue of $7.7 billion-$8.5 billion versus the $7.0 billion consensus, and EPS of $2.00-$2.30 versus $1.81 expected. Benzinga article
- Positive Sentiment: Growth was broad-based, with NAND revenue more than doubling sequentially and customer-support revenue reaching a third consecutive record. Management also highlighted accelerating demand for memory, advanced packaging and wafer-fabrication equipment as AI infrastructure investment expands. Zacks article
- Positive Sentiment: Needham reaffirmed its Buy rating and set a $390 price target, suggesting continued analyst confidence in Lam Research’s earnings growth. Benzinga analyst update
- Neutral Sentiment: Erste Group modestly raised its fiscal 2027 EPS forecast to $8.05 from $7.98 but retained a Hold rating.
- Negative Sentiment: B. Riley lowered its price target to $350 from $385, although it maintained a Buy rating and still sees meaningful upside. Investors also continue to monitor China-related equipment risks and the sector’s elevated valuation following its rebound. Benzinga analyst update
Institutional Trading of Lam Research
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Brighton Jones LLC lifted its holdings in shares of Lam Research by 1,032.4% in the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after buying an additional 12,936 shares during the period. First Foundation Advisors acquired a new position in shares of Lam Research in the 3rd quarter valued at $236,000. Crusonia Wealth Advisors LLC purchased a new stake in Lam Research during the fourth quarter worth $211,000. Synergy Financial Group LTD purchased a new position in Lam Research in the fourth quarter valued at $211,000. Finally, Earnest Partners LLC acquired a new stake in Lam Research in the fourth quarter valued at approximately $209,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More
- Five stocks we like better than Lam Research
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
